Anthony Kanelidis, MD, is a board-certified cardiologist dedicated to advanced heart failure and transplant cardiology. With a profound understanding of complex heart diseases, Dr. Kanelidis focuses on providing comprehensive care for patients with genetic cardiomyopathy, heart failure and those requiring heart transplants or left ventricular assist devices (LVAD).
Recognizing that heart disease impacts each individual differently, Dr. Kanelidis is passionate about fostering a supportive and compassionate relationship. He uses a patient-centric approach to care that emphasizes the importance of personalized treatment plans that address his patient’s conditions, symptoms and overall healthcare goals. His expertise spans the full spectrum of heart failure management, including staying at the forefront of advancements in heart disease to deliver the best possible outcomes.
Along with a commitment to his clinical practice, Dr. Kanelidis is also actively involved in research and clinical trials aimed at advancing the field of cardiology. His recent publication helps risk stratify which patients may need urgent heart transplantation or LVAD therapy. He is also conducting a clinical trial for patients undergoing LVAD implantation while proactively protecting the right side of the heart. His work focuses on developing innovative treatments and improving existing patient protocols for managing heart failure, LVAD, and heart transplant. This ongoing devotion to improving heart disease treatment not only enhances his clinical practice, but also contributes to the broader medical community’s understanding of cardiovascular health.
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2025 Feb 13.
PMID: 39954845
Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock.
Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock. Eur Heart J Open. 2024 Sep; 4(5):oeae072.
PMID: 39328214
New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis.
New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis. JACC Case Rep. 2024 Jun 05; 29(11):102358.
PMID: 38765201
ATTR Gene Variants in HCM.
ATTR Gene Variants in HCM. JACC Case Rep. 2024 Mar 20; 29(6):102236.
PMID: 38549855
Status One and Status Two Exception Use in the Updated Heart Allocation System.
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
PMID: 36966881
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices.
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
PMID: 36305735
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study.
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study. Artif Organs. 2022 Dec; 46(12):2382-2390.
PMID: 36574590
Takotsubo Syndrome from Coronavirus Disease 2019.
Takotsubo Syndrome from Coronavirus Disease 2019. J Am Soc Echocardiogr. 2022 08; 35(8):883-885.
PMID: 35491010
Left Ventricular Hemodynamics: Can a Direct Assessment of Left Ventricular Performance Help to Guide Myocardial Recovery in LVAD Recipients?
Left Ventricular Hemodynamics: Can a Direct Assessment of Left Ventricular Performance Help to Guide Myocardial Recovery in LVAD Recipients? J Card Fail. 2022 05; 28(5):807-809.
PMID: 35114383
ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy.
ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy. JACC CardioOncol. 2021 Oct; 3(4):598-601.
PMID: 34729534